InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
80.34
(
-0.30%
)
Bitcoin
69,542.67
(
1.86%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ocyanblue

Send PM Follow Ignore
Followers 0
Posts 167
Boards Moderated 0
Alias Born 03/28/2005

ocyanblue

Re: bobrmd post# 3954

Thursday, 05/31/2007 10:25:11 PM

Thursday, May 31, 2007 10:25:11 PM

Post# of 12660
I agree. There are also factors related only to trial conduct that affects the analysis. For example, about 10% of the 9902a treatment arm did not get fully treated. That got to have some confounding effect on the final results. Hopefully IMPACT will do better with that. In addition, with a much larger enrollment number, the imbalances will be less pronounced.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up